Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

THE GENETICS OF CAENORHABDITIS ELEGANS

Brenner, S. (1974) · Genetics · doi:10.1093/genetics/77.1.71 · Cited by 15,220

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

A second generation human haplotype map of over 3.1 million SNPs

The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326

C. elegans : des neurones et des gènes

Gally, C., & Bessereau, J. (2003) · médecine/sciences · doi:10.1051/medsci/20031967725 · Cited by 3,260

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234

Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs

Park, S.-K., Ratia, K. M., Ba, M. A., Valencik, M. L., & Liebman, S. W. (2016) · Microbial Cell · doi:10.15698/mic2016.02.476 · Cited by 21

Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies

Jiang, Y., & MacNeil, L. T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00664-x · Cited by 22

Genome-wide significant, replicated and functional risk variants for Alzheimer’s disease

Guo, X., Qiu, W., García-Milian, R., Lin, X., Zhang, Y., Cao, Y., Tan, Y., Wang, Z., Shi, J., Wang, J., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1773-0 · Cited by 18

Protein aggregation propensity is a crucial determinant of intracellular inclusion formation and quality control degradation

Villar‐Piqué, A., & Ventura, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.023 · Cited by 19

Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer’s Disease

Moosavi, B., Mousavi, B., & Macreadie, I. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150173 · Cited by 19

Unraveling Alzheimer’s Disease Using Drosophila

Yeates, C. J., Sarkar, A., Kango‐Singh, M., & Singh, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_9 · Cited by 18

Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models

Navarro‐Hortal, M. D., Romero‐Márquez, J. M., Osta, S., Jiménez-Trigo, V., Muñoz-Ollero, P., & Varela‐López, A. (2022) · Diseases · doi:10.3390/diseases10020028 · Cited by 18

Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects

Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 19

Synthesis and structure–activity relationship of 2,6-disubstituted pyridine derivatives as inhibitors of β-amyloid-42 aggregation

Kroth, H., Sreenivasachary, N., Hamel, A., Benderitter, P., Varisco, Y., Giriens, V., Paganetti, P., Froestl, W., Pfeifer, A., & Muhs, A. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.05.040 · Cited by 18

Oil Palm Phenolics Inhibit theIn VitroAggregation ofβ-Amyloid Peptide into Oligomeric Complexes

Weinberg, R. P., Koledova, V. V., Shin, H., Park, J. H., Tan, Y., Sinskey, A. J., Sambanthamurthi, R., & Rha, C. (2018) · International Journal of Alzheimer s Disease · doi:10.1155/2018/7608038 · Cited by 18

Characterization of hippocampal Cajal-Retzius cells during development in a mouse model of Alzheimer’s disease (Tg2576)

Deng, J., Yu, D., Fan, W., Wu, P., Liu, J., Niu, Y., & Li, M. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.128243 · Cited by 18

Dihydropyrimidine-Thiones and Clioquinol Synergize To Target β-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism

Tardiff, D. F., Brown, L. E., Yan, X., Trilles, R. V., Jui, N. T., Barrasa, M. I., Caldwell, K. A., Caldwell, G. A., Schaus, S. E., & Lindquist, S. L. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00187 · Cited by 16

Dysfunction of different cellular degradation pathways contributes to specific β‐amyloid42‐induced pathologies

Ji, X., Cheng, K., Chen, Y., Lin, T., Cheung, C. H. A., Wu, C., & Chiang, H. (2017) · The FASEB Journal · doi:10.1096/fj.201700199rr · Cited by 18

The Impact of ESCRT on Aβ1-42 Induced Membrane Lesions in a Yeast Model for Alzheimer’s Disease

Fruhmann, G., Marchal, C., Vignaud, H., Verduyckt, M., Talarek, N., VIRGILIO, C. D., Winderickx, J., & Cullin, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00406 · Cited by 17

Synthetic toxic Aβ 1–42 oligomers can assemble in different morphologies

Bobo, C., Chaignepain, S., Henry, S., Vignaud, H., Améadan, A., Marchal, C., Prado, É., Doutch, J., Schmitter, J., Nardin, C., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.03.001 · Cited by 16

Rab11-mediated recycling endosome role in nervous system development and neurodegenerative diseases

Zhang, J., Su, G., Wu, Q., Liu, J., Tian, Y., Liu, X., Zhou, J., Gao, J., Chen, W., Chen, D., et al. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1761354 · Cited by 18

PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Aβ42 toxicity

Yu, Y., Niccoli, T., Ren, Z., Woodling, N. S., Aleyakpo, B., Szabadkai, G., & Partridge, L. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa125 · Cited by 19

Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities

Torres, A. K., Mira, R. G., Pinto, C., & Inestrosa, N. C. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1559151 · Cited by 19

Yeast models of neurodegenerative diseases

Tuite, M. F. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.001 · Cited by 15

Identifying Anti-prion Chemical Compounds Using a Newly Established Yeast High-Throughput Screening System

Du, Z., Valtierra, S., Cardona, L. R., Dunne, S. F., Luan, C.-H., & Li, L. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.10.004 · Cited by 15

Yeast as a model eukaryote in toxinology: A functional genomics approach to studying the molecular basis of action of pharmacologically active molecules

Ušaj, M. M., Petrovič, U., & Križaj, I. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.03.014 · Cited by 15

Differential Effects of Alzheimer’s Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking

Omtri, R. S., Thompson, K. J., Tang, X., Gali, C. C., Panzenboeck, U., Davidson, M. W., Kalari, K. R., & Kandimalla, K. K. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.003 · Cited by 14

C. elegans to model autophagy-related human disorders

Wong, S. Q., Kumar, A. V., Mills, J., & Lapierre, L. R. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.01.007 · Cited by 14

Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases

Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000025 · Cited by 18

The Expression of Neuronal Sorting Nexin 8 (SNX8) Exacerbates Abnormal Cholesterol Levels

Muirhead, G., & Dev, K. K. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0209-z · Cited by 16

Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM

Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 15

Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson’s disease models

Nourse, J. B., Russell, S. N., Moniz, N. A., Peter, K., Seyfarth, L. M., Scott, M., Park, H., Caldwell, K. A., & Caldwell, G. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210712120 · Cited by 15

Role of frameshift ubiquitin B protein in Alzheimer's disease

Chen, X., & Petranović, D. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1340 · Cited by 14

Nonantioxidant Tetramethoxystilbene Abrogates α-Synuclein-Induced Yeast Cell Death but Not That Triggered by the Bax or βA4 Peptide

Derf, A., Mudududdla, R., Akintade, D. D., Williams, I. S., Abdullaha, M., Chaudhuri, B., & Bharate, S. B. (2018) · ACS Omega · doi:10.1021/acsomega.8b01154 · Cited by 14

Association of Alzheimer’s disease risk variants on the PICALM gene with PICALM expression, core biomarkers, and feature neurodegeneration

Xu, W., Initiative, A. D. N., Tan, C., Cao, X., & Tan, L. (2020) · Aging · doi:10.18632/aging.103814 · Cited by 16

Sphingolipids and Inositol Phosphates Regulate the Tau Protein Phosphorylation Status in Humanized Yeast

Rández‐Gil, F., Bojunga, L., Estruch, F., Winderickx, J., Poeta, M. D., & Prieto, J. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.592159 · Cited by 14

Cell Based Assays: the Cell Cycle, Cell Proliferation and Cell Death

Cobb, L. J. (2013) · Materials and Methods · doi:10.13070/mm.en.3.172 · Cited by 14

β‐sheet assembly in amyloidogenic glutamic acid nanostructures: Insights from X‐ray scattering and infrared nanospectroscopy

de Mello, L. R., Hamley, I. W., Miranda, A., Alves, W. A., & da Silva, E. R. (2019) · Journal of Peptide Science · doi:10.1002/psc.3170 · Cited by 14

Expression of the amyloid-β peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response

Sinnige, T., Ciryam, P. S., Casford, S., Dobson, C. M., de Bono, M., & Vendruscolo, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217746 · Cited by 18

A high throughput drug screening paradigm using transgenic Caenorhabditis elegans model of Alzheimer’s disease

Teo, E., Lim, J., Fong, S., Larbi, A., Wright, G. D., Tolwinski, N. S., & Gruber, J. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.12.002 · Cited by 18

Identification and Rescue of -Synuclein Toxicity in Parkinson Patient-Derived Neurons

Chung, C. Y., Khurana, V., Auluck, P. K., Tardiff, D. F., Mazzulli, J. R., Soldner, F., Baru, V., Lou, Y., Freyzon, Y., Cho, S., et al. (2013) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 13

Splice isoform and pharmacological studies reveal that sterol depletion relocalizes α-synuclein and enhances its toxicity

Valastyan, J. S., Termine, D. J., & Lindquist, S. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324209111 · Cited by 14

Mitochondrial energy metabolism is required for lifespan extension by the spastic paraplegia-associated protein spartin

Ring, J., Rockenfeller, P., Abraham, C., Tadić, J., Poglitsch, M., Schimmel, K., Westermayer, J., Schauer, S., Achleitner, B., Schimpel, C., et al. (2017) · Microbial Cell · doi:10.15698/mic2017.12.603 · Cited by 13

Yeast Systems Biology

Castrillo, J. I., Pir, P., & Oliver, S. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385944-0.00018-6 · Cited by 14

Yeast contributions to Alzheimer’s Disease

McDonald, J. B., Dhakal, S., & Macreadie, I. G. (2020) · Journal of Human and Clinical Genetics · doi:10.29245/2690-0009/2020/2.1114 · Cited by 13

Yeast red pigment modifies Amyloid beta growth in Alzheimer disease models in both Saccharomyces cerevisiae and Drosophila melanogaster

Nevzglyadova, O. V., Mikhailova, E. V., Amen, T., Zenin, V. V., Artemov, A. V., Kostyleva, E. I., Mezhenskaya, D. А., Rodin, D., Saifitdinova, A. F., Khodorkovskii, M. A., et al. (2015) · Amyloid · doi:10.3109/13506129.2015.1010038 · Cited by 12

Yeast Phenomics: An Experimental Approach for Modeling Gene Interaction Networks that Buffer Disease

Hartman, J. L., Stisher, C., Outlaw, D. A., Guo, J., Shah, N. A., Tian, D., Santos, S. M., Rodgers, J. W., & White, R. (2015) · Genes · doi:10.3390/genes6010024 · Cited by 12

Blood–Brain Barrier Transport of Alzheimer’s Amyloid β-Peptide

Nelson, A. R., Sagare, A. P., & Zloković, B. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00009-5 · Cited by 12

C. elegans as a Model for Synucleinopathies and Other Neurodegenerative Diseases: Tools and Techniques

Koopman, M., Seinstra, R. I., & Nollen, E. A. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9124-2_9 · Cited by 12

Protein Quantitation

Johnson, M. A. (2012) · Materials and Methods · doi:10.13070/mm.en.2.115 · Cited by 12

Dab1‐mediated colocalization of multi‐adaptor protein CIN85 with Reelin receptors, A po ER 2 and VLDLR , in neurons

Fuchigami, T., Sato, Y., Tomita, Y., Takano, T., Miyauchi, S., Tsuchiya, Y., Saito, T., Kubo, K., Nakajima, K., Fukuda, M., et al. (2013) · Genes to Cells · doi:10.1111/gtc.12045 · Cited by 13

Amyloid fibrils compared to peptide nanotubes

Žganec, M., & Žerovnik, E. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.05.019 · Cited by 12

Yeast Informs Alzheimer's Disease

McGurk, L., & Bonini, N. M. (2011) · Science · doi:10.1126/science.1216073 · Cited by 12

Computational analysis of functional SNPs in Alzheimer’s disease-associated endocytosis genes

Tey, H. J., & Ng, C. H. (2019) · PeerJ · doi:10.7717/peerj.7667 · Cited by 11

Heterologous Expression and Assembly of Human TLR Signaling Components in Saccharomyces cerevisiae

Coronas-Serna, J. M., del Val, E., Kagan, J. C., Molina, M., & Cid, V. J. (2021) · Biomolecules · doi:10.3390/biom11111737 · Cited by 10

Amyloid cascade hypothesis, tau synthesis, and role of oxidative stress in AD

Vyas, J., Raytthatha, N., & Prajapati, B. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00023-6 · Cited by 13

Calcium-responsive transactivator (CREST) toxicity is rescued by loss of PBP1/ATXN2 function in a novel yeast proteinopathy model and in transgenic flies

Park, S., Park, S.-K., Watanabe, N., Hashimoto, T., Iwatsubo, T., Shelkovnikova, T. A., & Liebman, S. W. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008308 · Cited by 11

Screening of Crucial Differentially-Methylated/Expressed Genes for Alzheimer’s Disease

Qiu, H., & Weng, Q. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221116220 · Cited by 10

A lzheimer's Disease Biomarkers: More Than Molecular Diagnostics

Anderson, D. C. (2013) · Drug Development Research · doi:10.1002/ddr.21073 · Cited by 9

Homo cerevisiae—Leveraging Yeast for Investigating Protein–Protein Interactions and Their Role in Human Disease

Laval, F., Coppin, G., Twizere, J., & Vidal, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119179 · Cited by 10

Necrotic cell death and neurodegeneration

Troulinaki, K., & Tavernarakis, N. (2012) · Worm · doi:10.4161/worm.20457 · Cited by 10

Effects of estradiol on the endocytic transport of vitamin D carrier protein in hepatocytes

Pirani, T., Chen, J., & Vieira, A. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.025 · Cited by 10

An Apoptotic and Endosymbiotic Explanation of the Warburg and the Inverse Warburg Hypotheses

Kaczanowski, S., Klim, J., & Zielenkiewicz, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103100 · Cited by 9

Approaching the Functional Annotation of Fungal Virulence Factors Using Cross-Species Genetic Interaction Profiling

Brown, J. C. S., & Madhani, H. D. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003168 · Cited by 10

Proteome-Scale Mapping of Perturbed Proteostasis in Living CellsPreprint

Lam, I., Hallacli, E., & Khurana, V. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034124 · Cited by 9

Amyloidogenic propensity of self-assembling peptides and their adjuvant potential for use as DNA vaccines

Shrimali, P. C., Chen, S., Das, A., Dreher, R. D., Howard, M. K., Ryan, J. J., Buck, J., Kim, D., Sprunger, M. L., Rudra, J. S., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.08.015 · Cited by 9

Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core.

Kroth, H., Oden, F., Serra, A., Molette, J., Mueller, A., Berndt, M., Capotosti, F., Gabellieri, E., Schmitt-Willich, H., Hickman, D., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116528 · Cited by 7

Yeast models for amyloid disease

Panaretou, B., & Jones, G. W. (2014) · Essays in Biochemistry · doi:10.1042/bse0560085 · Cited by 10

The Genetic Basis of Alzheimer's Disease

Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00034-2 · Cited by 9

Delineation of the molecular mechanism for disulfide stress-induced aluminium toxicity

Wu, M. J., Murphy, P. A., O’Doherty, P. J., Mieruszynski, S., Jones, M., Kersaitis, C., Rogers, P. J., Bailey, T. D., & Higgins, V. J. (2012) · BioMetals · doi:10.1007/s10534-012-9534-x · Cited by 8

Genome-wide association study of white matter hyperintensity volume in elderly persons without dementia

Guo, Y., Shen, X., Hou, X., Ou, Y., Huang, Y., Dong, Q., Tan, L., & Yu, J. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102209 · Cited by 8

Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c’]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer’s disease and other tauopathies

Gabellieri, E., Capotosti, F., Molette, J., Sreenivasachary, N., Mueller, A., Berndt, M., Schieferstein, H., Juergens, T., Varisco, Y., Oden, F., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112615 · Cited by 9

Invited review: Unearthing the mechanisms of age-related neurodegenerative disease using Caenorhabditis elegans

Hayden, A. N., Leptich, E. J., & Arey, R. N. (2022) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2022.111166 · Cited by 8

Caenorhabditis elegans as a model system to evaluate neuroprotective potential of nano formulations

Chauhan, P., Wadhwa, K., & Singh, G. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.1018754 · Cited by 8

Age-dependent small fiber neuropathy: Mechanistic insights from animal models

Taub, D. G., & Woolf, C. J. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114811 · Cited by 7

Clioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage

Zheng, Q., Zhu, H., Lv, C., Zhu, Z., Cui, H., Fan, Z., Sun, J., Huang, Z., & Shi, P. (2024) · Biotechnology Journal · doi:10.1002/biot.202300662 · Cited by 7

Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization

Amen, T., & Kaganovich, D. (2016) · Microbial Cell · doi:10.15698/mic2016.03.482 · Cited by 7

The functional study of human proteins using humanized yeast

Kim, S., Park, J., Kim, T., & Lee, J. (2020) · The Journal of Microbiology · doi:10.1007/s12275-020-0136-y · Cited by 10

Back to the future through the wormhole: Caenorhabditis elegans as a preclinical model

Caldwell, G. A. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050333 · Cited by 7

Supervised latent factor modeling isolates cell-type-specific transcriptomic modules that underlie Alzheimer’s disease progression

Hodgson, L. M., Li, Y., Iturria‐Medina, Y., Stratton, J. A., Wolf, G., Krishnaswamy, S., Bennett, D. A., & Bzdok, D. (2024) · Communications Biology · doi:10.1038/s42003-024-06273-8 · Cited by 7

Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation

Danhash, E., Verbeck, A. C., Western, D., Díaz‐Pacheco, A. S., Galasso, G., You, S., Huang, G., Starr, E., Miller, N., Nadarajah, C. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70580 · Cited by 6

Enlargement of early endosomes and traffic jam in basal forebrain cholinergic neurons in Alzheimer's disease

Fahimi, A., Noroozi, M., & Salehi, A. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00011-x · Cited by 6

A Genome-Wide Functional Screen Identifies Enhancer and Protective Genes for Amyloid Beta-Peptide Toxicity

Picón-Pagès, P., Bosch-Morató, M., Subirana, L., Rubio-Moscardó, F., Guivernau, B., Fanlo-Ucar, H., Zeylan, M. E., Senyuz, S., Herrera-Fernández, V., Vicente, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021278 · Cited by 6

Alzheimer’s Disease: Significant Benefit from the Yeast-Based Models

Epremyan, K. K., Mamaev, D. V., & Zvyagilskaya, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129791 · Cited by 7

Graphene Oxide Attenuates Toxicity of Amyloid‐β Aggregates in Yeast by Promoting Disassembly and Boosting Cellular Stress Response

Chen, X., Pandit, S., Shi, L., Ravikumar, V., Køhler, J. B., Svetličić, E., Cao, Z., Garg, A., Petranović, D., & Mijakovic̀, I. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202304053 · Cited by 6

Neurodegenerative disease-associated inclusion bodies are cleared by selective autophagy in budding yeast

Folger, A., Chen, C., Kabbaj, M.-H. M., Frey, K., & Wang, Y. (2023) · Autophagy Reports · doi:10.1080/27694127.2023.2236407 · Cited by 6

One cell, one love: a journal for microbial research

Carmona‐Gutiérrez, D., Kroemer, G., & Madeo, F. (2014) · Microbial Cell · doi:10.15698/mic2014.01.118 · Cited by 6

The Genetic Basis of Alzheimer’s Disease

Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00002-2 · Cited by 6

A rapid absorbance-based growth assay to screen the toxicity of oligomer Aβ42 and protect against cell death in yeast

Bharadwaj, P., & Martins, R. N. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.280318 · Cited by 6

The Role of Genetics in Alzheimer's Disease and Parkinson's Disease

Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6

Multiplex neurodegeneration proteotoxicity platform reveals DNAJB6 promotes non-toxic FUS condensate gelation and inhibits neurotoxicity

Resnick, S. J., Qamar, S., Krishna, P., Korben, V. A., Ausserwöger, H., Miller, A., Esposito, P., Varela, J. A., Sheng, J., Huang, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65178-0 · Cited by 7

Tau Protein Disrupts Mitochondrial Homeostasis in a Yeast Model: Implications for Alzheimer’s Disease

Castillo-Casaña, Y., Kawasaki, L., Arias, C., Ruelas-Ramírez, H., Funes, S., Sánchez, N. S., CODIZ-HUERTA, M. G., Ongay‐Larios, L., & Coria, R. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05255-z · Cited by 5

Screening Assay for Small-Molecule Inhibitors of Synaptojanin 1, a Synaptic Phosphoinositide Phosphatase

McIntire, L. B., Lee, K.-I., Chang-Ileto, B., Paolo, G. D., & Kim, T. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113510177 · Cited by 5

The cellular machinery of post-endocytic APP trafficking in Alzheimer's disease: A future target for therapeutic intervention?

Goldstein, L. S. B., & Das, U. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.001 · Cited by 5

Yeast Tripartite Biosensors Sensitive to Protein Stability and Aggregation Propensity

Sachsenhauser, V., Deng, X., Kim, H.-H., Jankovic, M., & Bardwell, J. C. A. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00083 · Cited by 6

A multiplex platform to identify mechanisms and modulators of proteotoxicity in neurodegenerationPreprint

Resnick, S. J., Qamar, S., Sheng, J., Huang, L. H., Nixon‐Abell, J., Melore, S. M., Chung, C. W., Li, X., Wang, J., Zhang, N. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.19.508444 · Cited by 5

Mitochondrial Quality Control in Alzheimer’s Disease: Insights from Caenorhabditis elegans Models

Ganguly, U., Carroll, T., Nehrke, K. W., & Johnson, G. V. W. (2024) · Antioxidants · doi:10.3390/antiox13111343 · Cited by 5

Probing the drivers of Staphylococcus aureus biofilm protein amyloidogenesis and disrupting biofilms with engineered protein disaggregases

Howard, M. K., Miller, K. R., Sohn, B. S., Ryan, J. J., Xu, A., & Jackrel, M. E. (2023) · mBio · doi:10.1128/mbio.00587-23 · Cited by 8

PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer’s Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population

Liu, Y., Initiative, A. D. N., Wang, X.-J., Tan, L., Tan, C., & Xu, W. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230516 · Cited by 5

Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disorders

Panda, M., Fakitsa, M., Markaki, M., & Tavernarakis, N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115655 · Cited by 4

From Yeast to Therapeutics: Modeling Neurodegenerative Diseases in Saccharomyces cerevisiae

Ferreira-Júnior, J. R., Camandona, V. D. L., & de Barros, M. H. (2025) · Yeast · doi:10.1002/yea.70008 · Cited by 5

Comparative analysis of the intracellular responses to disease-related aggregation-prone proteins

Melnik, A., Cappelletti, V., Vaggi, F., Piazza, I., Tognetti, M., Schwarz, C., Cereghetti, G., Ahmed, M. A., Soste, M., Matlack, K. E. S., et al. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103862 · Cited by 4

Yeast Models of Amyotrophic Lateral Sclerosis Type 8 Mimic Phenotypes Seen in Mammalian Cells Expressing Mutant VAPBP56S

Stump, A. L., Rioux, D. J., Albright, R., Melki, G. L., & Prosser, D. C. (2023) · Biomolecules · doi:10.3390/biom13071147 · Cited by 3

A rare natural lipid induces neuroglobin expression to prevent amyloid oligomers toxicity and retinal neurodegeneration

Oamen, H. P., Romero, N. R., Knuckles, P., Saarikangas, J., Radman‐Livaja, M., Dong, Y., & Caudron, F. (2022) · Aging Cell · doi:10.1111/acel.13645 · Cited by 3

Prions and chaperones: Outside the fold

Trivedi, B. P. (2012) · Nature · doi:10.1038/482294a · Cited by 4

Functional links between Ab toxicity, endocytic trafficking, and Alzheimer’s disease risk factors in yeast. Science 334

Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E. S., Chung, C. Y., Baru, V., Shulman, J. M., Parrado, A., Bevis, B. J., Valastyan, J. S., et al. (2011)

Functional Links Between Ab Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E. S., Chung, C. Y., Baru, V., Shulman, J. M., Parrado, A., Bevis, B. J., Valastyan, J. S., et al. (2016)

If yeast had brains

Chen, I. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2201

PERSPECTIVES

(2011)

A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity

D’Angelo, F., Vignaud, H., Martino, J. S. D., Salin, B., Devin, A., Cullin, C., & Marchal, C. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010108 · Cited by 80